Literature DB >> 35892329

Hsp90 and Associated Co-Chaperones of the Malaria Parasite.

Tanima Dutta1,2,3, Harpreet Singh4, Adrienne L Edkins5, Gregory L Blatch1,2,5,6.   

Abstract

Heat shock protein 90 (Hsp90) is one of the major guardians of cellular protein homeostasis, through its specialized molecular chaperone properties. While Hsp90 has been extensively studied in many prokaryotic and higher eukaryotic model organisms, its structural, functional, and biological properties in parasitic protozoans are less well defined. Hsp90 collaborates with a wide range of co-chaperones that fine-tune its protein folding pathway. Co-chaperones play many roles in the regulation of Hsp90, including selective targeting of client proteins, and the modulation of its ATPase activity, conformational changes, and post-translational modifications. Plasmodium falciparum is responsible for the most lethal form of human malaria. The survival of the malaria parasite inside the host and the vector depends on the action of molecular chaperones. The major cytosolic P. falciparum Hsp90 (PfHsp90) is known to play an essential role in the development of the parasite, particularly during the intra-erythrocytic stage in the human host. Although PfHsp90 shares significant sequence and structural similarity with human Hsp90, it has several major structural and functional differences. Furthermore, its co-chaperone network appears to be substantially different to that of the human host, with the potential absence of a key homolog. Indeed, PfHsp90 and its interface with co-chaperones represent potential drug targets for antimalarial drug discovery. In this review, we critically summarize the current understanding of the properties of Hsp90, and the associated co-chaperones of the malaria parasite.

Entities:  

Keywords:  ATPase; Plasmodium falciparum; client proteins; co-chaperones; cytosolic Hsp90; heat shock proteins

Mesh:

Substances:

Year:  2022        PMID: 35892329      PMCID: PMC9332011          DOI: 10.3390/biom12081018

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  121 in total

1.  Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40.

Authors:  F Pirkl; J Buchner
Journal:  J Mol Biol       Date:  2001-05-11       Impact factor: 5.469

Review 2.  Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.

Authors:  William B Pratt; David O Toft
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

Review 3.  Structure and mechanism of the Hsp90 molecular chaperone machinery.

Authors:  Laurence H Pearl; Chrisostomos Prodromou
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

4.  Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms.

Authors:  Jill L Johnson; Celeste Brown
Journal:  Cell Stress Chaperones       Date:  2008-07-18       Impact factor: 3.667

5.  Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90.

Authors:  Edgar E Boczek; Lasse G Reefschläger; Marco Dehling; Tobias J Struller; Elisabeth Häusler; Andreas Seidl; Ville R I Kaila; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

6.  Characterization of Plasmodium falciparum co-chaperone p23: its intrinsic chaperone activity and interaction with Hsp90.

Authors:  Chun-Song Chua; Huiyu Low; Kian-Sim Goo; T S Sim
Journal:  Cell Mol Life Sci       Date:  2010-02-06       Impact factor: 9.261

Review 7.  Molecular chaperones and protein kinase quality control.

Authors:  Avrom J Caplan; Atin K Mandal; Maria A Theodoraki
Journal:  Trends Cell Biol       Date:  2006-12-20       Impact factor: 20.808

8.  Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone.

Authors:  Gregor P Lotz; Hongying Lin; Anja Harst; Wolfgang M J Obermann
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

9.  Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity.

Authors:  Dora Posfai; Amber L Eubanks; Allison I Keim; Kuan-Yi Lu; Grace Z Wang; Philip F Hughes; Nobutaka Kato; Timothy A Haystead; Emily R Derbyshire
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 10.  The Hsp70-Hsp90 go-between Hop/Stip1/Sti1 is a proteostatic switch and may be a drug target in cancer and neurodegeneration.

Authors:  Kaushik Bhattacharya; Didier Picard
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.